Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01) Download the PDF here. This post appeared first on investingnews.com admin Website Prev Post Asara raises $25m to accelerate exploration at Kada July 28, 2025 Next Post Trump’s exaggerated claim that Pennsylvania has 500,000 fracking jobs July 28, 2025 Related Posts West High Yield September 23, 2025 Silver Price Surges Above US$44 Following Fed Rate Decision September 23, 2025 DRC to End Cobalt Export Ban, Move to Quota System September 23, 2025